ReviewCurrent drug research reviews2025
Significance of Impurity Analysis in Antiviral Drug: A Critical Review.
Review in Current drug research reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Today's pharmaceutical products are seeing a massive increase in impurity profiling. A drug substance or product will inevitably contain contaminants in trace amounts. According to pharmaceutical chemistry, impurities are undesirable substances found in pharmaceutical compounds with therapeutic activity. Due to their extraordinary potency and likelihood of toxicity, they may exhibit unanticipated pharmacological effects that are detrimental to human health. For the pharmaceutical sector, impurity management is currently a major concern. The impurity can appear in medicines either during the formulation process or after the produced Active Pharmaceutical Ingredients (APIs) have aged. The term "impurity profiling" refers to a collection of analytical procedures that include characterizing, quantifying, and describing the known and unknown impurities found in novel pharmacological compounds. Highly sophisticated analytical techniques and instrumentation are essential for identifying small elements (drugs, contaminants, breakdown products, and metabolites) in diverse matrices. Current references and articles reveal different impurities found in the APIs of antiviral drugs, techniques for locating them, and potential countermeasures for the interferences they produce in pharmaceutical analysis. Antiviral medications are a class of medications used to treat viral infections. They work by preventing the growth of the pathogen they are intended to treat. Drugs that target viral activities must enter host cells because viruses are obligatory intracellular entities and prevent the production of viral DNA, which is subsequently converted to triphosphate. Regulatory authorities now need not just purity profiles but also impurity profiles. This review also covers the origins of impurities, how they are classified, and the different analytical techniques used to identify and quantify them. It also covers the simple, rapid, accurate, precise, and exact creation of innovative analytical techniques for determining impurity levels.
Indexed as
Identifiers
40051358What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.